This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenrick, R.
Right arrow Articles by Hiebert, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenrick, R.
Right arrow Articles by Hiebert, S. W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 1999, p. 6566-6574, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein

Randy Fenrick,1,2 Joseph M. Amann,1,2 Bart Lutterbach,1,2 Lilin Wang,1,2 Jennifer J. Westendorf,1,2 James R. Downing,3 and Scott W. Hiebert1,2,*

Department of Biochemistry1 and Vanderbilt Cancer Center,2 Vanderbilt University School of Medicine, Nashville, Tennessee 37232, and Department of Pathology and Laboratory of Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee 381053

Received 17 February 1999/Returned for modification 1 April 1999/Accepted 9 July 1999

t(12;21) is the most frequent translocation found in pediatric B-cell acute lymphoblastic leukemias. This translocation fuses a putative repressor domain from the TEL DNA-binding protein to nearly all of the AML-1B transcription factor. Here, we demonstrate that fusion of the TEL pointed domain to the GAL4 DNA-binding domain resulted in sequence-specific transcriptional repression, indicating that the pointed domain is a portable repression motif. The TEL pointed domain functioned equally well when the GAL4 DNA-binding sites were moved 600 bp from the promoter, suggesting an active mechanism of repression. This lead us to demonstrate that wild-type TEL and the t(12;21) fusion protein bind the mSin3A corepressor. In the fusion protein, both TEL and AML-1B contribute mSin3 interaction domains. Deletion mutagenesis indicated that both the TEL and AML-1B mSin3-binding domains contribute to repression by the fusion protein. While both TEL and AML-1B associate with mSin3A, TEL/AML-1B appears to bind this corepressor much more stably than either wild-type protein, suggesting a mode of action for the t(12;21) fusion protein.

* Corresponding author. Mailing address: Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Rm. 512 Medical Research Building II, 23rd and Pierce, Nashville, TN 37232. Phone: (615) 936-3582. Fax: (615) 936-1790. E-mail: scott.hiebert{at}mcmail.vanderbilt.edu.

Molecular and Cellular Biology, October 1999, p. 6566-6574, Vol. 19, No. 10
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Roudaia, L., Cheney, M. D., Manuylova, E., Chen, W., Morrow, M., Park, S., Lee, C.-T., Kaur, P., Williams, O., Bushweller, J. H., Speck, N. A. (2009). CBF{beta} is critical for AML1-ETO and TEL-AML1 activity. Blood 113: 3070-3079 [Abstract] [Full Text]  
  • Cheng, C. K., Li, L., Cheng, S. H., Lau, K. M., Chan, N. P. H., Wong, R. S. M., Shing, M. M. K., Li, C. K., Ng, M. H. L. (2008). Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia. Blood 112: 3391-3402 [Abstract] [Full Text]  
  • Starkova, J., Madzo, J., Cario, G., Kalina, T., Ford, A., Zaliova, M., Hrusak, O., Trka, J. (2007). The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells. Clin. Cancer Res. 13: 1726-1735 [Abstract] [Full Text]  
  • Carella, C., Potter, M., Bonten, J., Rehg, J. E., Neale, G., Grosveld, G. C. (2006). The ETS factor TEL2 is a hematopoietic oncoprotein. Blood 107: 1124-1132 [Abstract] [Full Text]  
  • Amann, J. M., Chyla, B. J. I., Ellis, T. C., Martinez, A., Moore, A. C., Franklin, J. L., McGhee, L., Meyers, S., Ohm, J. E., Luce, K. S., Ouelette, A. J., Washington, M. K., Thompson, M. A., King, D., Gautam, S., Coffey, R. J., Whitehead, R. H., Hiebert, S. W. (2005). Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine. Mol. Cell. Biol. 25: 9576-9585 [Abstract] [Full Text]  
  • Maki, K., Yamagata, T., Asai, T., Yamazaki, I., Oda, H., Hirai, H., Mitani, K. (2005). Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos. Blood 106: 2147-2155 [Abstract] [Full Text]  
  • Nakamura, F., Nakamura, Y., Maki, K., Sato, Y., Mitani, K. (2005). Cloning and Characterization of the Novel Chimeric Gene TEL/PTPRR in Acute Myelogenous Leukemia with inv(12)(p13q13). Cancer Res. 65: 6612-6621 [Abstract] [Full Text]  
  • Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., Speck, N. A., Gilliland, D. G. (2005). Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106: 494-504 [Abstract] [Full Text]  
  • Schick, N., Oakeley, E. J., Hynes, N. E., Badache, A. (2004). TEL/ETV6 Is a Signal Transducer and Activator of Transcription 3 (Stat3)-induced Repressor of Stat3 Activity. J. Biol. Chem. 279: 38787-38796 [Abstract] [Full Text]  
  • Kawagoe, H., Potter, M., Ellis, J., Grosveld, G. C. (2004). TEL2, an ETS Factor Expressed in Human Leukemia, Regulates Monocytic Differentiation of U937 Cells and Blocks the Inhibitory Effect of TEL1 on Ras-Induced Cellular Transformation. Cancer Res. 64: 6091-6100 [Abstract] [Full Text]  
  • So, C. W., Cleary, M. L. (2004). Dimerization: a versatile switch for oncogenesis. Blood 104: 919-922 [Abstract] [Full Text]  
  • Asakura, K., Uchida, H., Miyachi, H., Kobayashi, H., Miyakawa, Y., Nimer, S. D., Takahashi, H., Ikeda, Y., Kizaki, M. (2004). TEL/AML1 Overcomes Drug Resistance Through Transcriptional Repression of Multidrug Resistance-1 Gene Expression. Mol Cancer Res 2: 339-347 [Abstract] [Full Text]  
  • Maki, K., Arai, H., Waga, K., Sasaki, K., Nakamura, F., Imai, Y., Kurokawa, M., Hirai, H., Mitani, K. (2004). Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation. Mol. Cell. Biol. 24: 3227-3237 [Abstract] [Full Text]  
  • Moqattash, S., Lutton, J. D. (2004). Leukemia Cells and the Cytokine Network: Therapeutic Prospects. Exp. Biol. Med. 229: 121-137 [Abstract] [Full Text]  
  • Lopez, R. G., Carron, C., Ghysdael, J. (2003). v-SRC Specifically Regulates the Nucleo-cytoplasmic Delocalization of the Major Isoform of TEL (ETV6). J. Biol. Chem. 278: 41316-41325 [Abstract] [Full Text]  
  • Boccuni, P., MacGrogan, D., Scandura, J. M., Nimer, S. D. (2003). The Human L(3)MBT Polycomb Group Protein Is a Transcriptional Repressor and Interacts Physically and Functionally with TEL (ETV6). J. Biol. Chem. 278: 15412-15420 [Abstract] [Full Text]  
  • Wood, L. D., Irvin, B. J., Nucifora, G., Luce, K. S., Hiebert, S. W. (2003). Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl. Acad. Sci. USA 100: 3257-3262 [Abstract] [Full Text]  
  • Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., Hiebert, S. W. (2003). The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain. Mol. Cell. Biol. 23: 607-619 [Abstract] [Full Text]  
  • Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., Ozato, K. (2002). Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element. Mol. Cell. Biol. 22: 7439-7448 [Abstract] [Full Text]  
  • Reddy, V. A., Iwama, A., Iotzova, G., Schulz, M., Elsasser, A., Vangala, R. K., Tenen, D. G., Hiddemann, W., Behre, G. (2002). Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 100: 483-490 [Abstract] [Full Text]  
  • Seidel, J. J., Graves, B. J. (2002). An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16: 127-137 [Abstract] [Full Text]  
  • Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B., Harada, H., Lenny, N., Downing, J. R., Meyers, S., Hiebert, S. W. (2001). ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain. Mol. Cell. Biol. 21: 6470-6483 [Abstract] [Full Text]  
  • Yang, S.-H., Vickers, E., Brehm, A., Kouzarides, T., Sharrocks, A. D. (2001). Temporal Recruitment of the mSin3A-Histone Deacetylase Corepressor Complex to the ETS Domain Transcription Factor Elk-1. Mol. Cell. Biol. 21: 2802-2814 [Abstract] [Full Text]  
  • Zhang, J., Hug, B. A., Huang, E. Y., Chen, C. W., Gelmetti, V., Maccarana, M., Minucci, S., Pelicci, P. G., Lazar, M. A. (2001). Oligomerization of ETO Is Obligatory for Corepressor Interaction. Mol. Cell. Biol. 21: 156-163 [Abstract] [Full Text]  
  • Buijs, A., van Rompaey, L., Molijn, A. C., Davis, J. N., Vertegaal, A. C. O., Potter, M. D., Adams, C., van Baal, S., Zwarthoff, E. C., Roussel, M. F., Grosveld, G. C. (2000). The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity. Mol. Cell. Biol. 20: 9281-9293 [Abstract] [Full Text]  
  • Chakrabarti, S. R., Sood, R., Nandi, S., Nucifora, G. (2000). Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. USA 10.1073/pnas.240315897v1 [Abstract] [Full Text]  
  • BURKE, L. J., BANIAHMAD, A. (2000). Co-repressors 2000. FASEB J. 14: 1876-1888 [Abstract] [Full Text]  
  • Guidez, F., Petrie, K., Ford, A. M., Lu, H., Bennett, C. A., MacGregor, A., Hannemann, J., Ito, Y., Ghysdael, J., Greaves, M., Wiedemann, L. M., Zelent, A. (2000). Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96: 2557-2561 [Abstract] [Full Text]  
  • Fenrick, R., Wang, L., Nip, J., Amann, J. M., Rooney, R. J., Walker-Daniels, J., Crawford, H. C., Hulboy, D. L., Kinch, M. S., Matrisian, L. M., Hiebert, S. W. (2000). TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1. Mol. Cell. Biol. 20: 5828-5839 [Abstract] [Full Text]  
  • Melnick, A. M., Westendorf, J. J., Polinger, A., Carlile, G. W., Arai, S., Ball, H. J., Lutterbach, B., Hiebert, S. W., Licht, J. D. (2000). The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein. Mol. Cell. Biol. 20: 2075-2086 [Abstract] [Full Text]  
  • Huang, S., Brandt, S. J. (2000). mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor. Mol. Cell. Biol. 20: 2248-2259 [Abstract] [Full Text]  
  • Lutterbach, B., Westendorf, J. J., Linggi, B., Isaac, S., Seto, E., Hiebert, S. W. (2000). A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia. J. Biol. Chem. 275: 651-656 [Abstract] [Full Text]  
  • Lutterbach, B., Hou, Y., Durst, K. L., Hiebert, S. W. (1999). The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc. Natl. Acad. Sci. USA 96: 12822-12827 [Abstract] [Full Text]  
  • Gu, X., Shin, B.-H., Akbarali, Y., Weiss, A., Boltax, J., Oettgen, P., Libermann, T. A. (2001). Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6. J. Biol. Chem. 276: 9421-9436 [Abstract] [Full Text]  
  • Salomon-Nguyen, F., Della-Valle, V., Mauchauffe, M., Busson-Le Coniat, M., Ghysdael, J., Berger, R., Bernard, O. A. (2000). The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc. Natl. Acad. Sci. USA 97: 6757-6762 [Abstract] [Full Text]  
  • Chakrabarti, S. R., Sood, R., Nandi, S., Nucifora, G. (2000). Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. USA 97: 13281-13285 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»